Similarly, in triple-negative breast cancer, the SEMA3B-AS1 plays a role as a decoy for miR-3940-3p to inhibit the degradation of its target gene KLLN (Hu et al. 2022). Here, SEMA3B is linked to triple-negative breast carcinoma.